Beryl Drugs Limited
Beryl Drugs Limited has submitted a regulatory disclosure to BSE Limited regarding temporary unavailability of the company's corporate website.
Technical Issue Details
The company's website "www.beryldrugs.com" has become temporarily unavailable due to an unexpected technical issue. The company identified the issue and immediately initiated corrective measures in coordination with its technical service providers.
Current Status
Restoration activities are currently underway, and the company is making all reasonable efforts to resume normal website operations at the earliest.
Operational Impact Assessment
The company states that the temporary disruption affects only the accessibility of the company's website. There has been no impact on the company's business operations, financial systems, or statutory records, to the best of the company's knowledge as of the date of this intimation (20.07.2026).
Regulatory Compliance Commitment
The company remains committed to ensuring compliance with all applicable provisions of the SEBI LODR Regulations and the Companies Act, 2013. Any material developments regarding this issue, including the restoration of the website, shall be intimated to the Stock Exchange if considered necessary under the applicable regulatory framework.